Literature DB >> 23061425

Beckwith-Wiedemann syndrome and long QT syndrome due to familial-balanced translocation t(11;17)(p15.5;q21.3) involving the KCNQ1 gene.

S Kaltenbach1, Y Capri, S Rossignol, I Denjoy, S Soudée, A Aboura, C Baumann, A Verloes.   

Abstract

We report a child with Beckwith-Wiedemann syndrome (BWS) as the consequence of an apparently balanced, maternally inherited reciprocal translocation t(11;17)(p15.5;q21.3). His mother and aunt, who inherited the translocation from their father, did not have BWS. At birth, long QT syndrome (LQTS) was diagnosed in this child and, secondarily, among apparently healthy family members carrying the translocation. By FISH analysis, the breakpoint in 11p15.5 interrupts the KCNQ1 gene between exons 2 and 10 and causes a loss of methylation of the IC2 (and thus BWS) on the maternally inherited der(11) chromosome. To explain the presence of LQTS segregating with the t(11;17) translocation in this family, we hypothesize that the translocation that interrupts KCNQ1 allow translation of an abnormal short allele that interferes in a dominant negative way with the normal isoform 1 of KCNQ1 in the heart (where this allele is not subject to parental imprint). This appears to be the first report of BWS with congenital LQTS, which should be considered as a rare but serious complication to be searched systematically in patients with BWS due to 11p15 rearrangements.
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061425     DOI: 10.1111/cge.12038

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

1.  Blocked transcription through KvDMR1 results in absence of methylation and gene silencing resembling Beckwith-Wiedemann syndrome.

Authors:  Vir B Singh; Sirinapa Sribenja; Kayla E Wilson; Kristopher M Attwood; Joanna C Hillman; Shilpa Pathak; Michael J Higgins
Journal:  Development       Date:  2017-04-20       Impact factor: 6.868

2.  Disruption of KCNQ1 prevents methylation of the ICR2 and supports the hypothesis that its transcription is necessary for imprint establishment.

Authors:  Jasmin Beygo; Joachim Bürger; Tim M Strom; Sabine Kaya; Karin Buiting
Journal:  Eur J Hum Genet       Date:  2019-02-18       Impact factor: 4.246

Review 3.  Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement.

Authors:  Frédéric Brioude; Jennifer M Kalish; Alessandro Mussa; Alison C Foster; Jet Bliek; Giovanni Battista Ferrero; Susanne E Boonen; Trevor Cole; Robert Baker; Monica Bertoletti; Guido Cocchi; Carole Coze; Maurizio De Pellegrin; Khalid Hussain; Abdulla Ibrahim; Mark D Kilby; Malgorzata Krajewska-Walasek; Christian P Kratz; Edmund J Ladusans; Pablo Lapunzina; Yves Le Bouc; Saskia M Maas; Fiona Macdonald; Katrin Õunap; Licia Peruzzi; Sylvie Rossignol; Silvia Russo; Caroleen Shipster; Agata Skórka; Katrina Tatton-Brown; Jair Tenorio; Chiara Tortora; Karen Grønskov; Irène Netchine; Raoul C Hennekam; Dirk Prawitt; Zeynep Tümer; Thomas Eggermann; Deborah J G Mackay; Andrea Riccio; Eamonn R Maher
Journal:  Nat Rev Endocrinol       Date:  2018-01-29       Impact factor: 43.330

4.  The role of CTCF in the organization of the centromeric 11p15 imprinted domain interactome.

Authors:  Natali S Sobel Naveh; Daniel F Deegan; Jacklyn Huhn; Emily Traxler; Yemin Lan; Rosanna Weksberg; Arupa Ganguly; Nora Engel; Jennifer M Kalish
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

5.  Large deletion in KCNQ1 identified in a family with Jervell and Lange-Nielsen syndrome.

Authors:  Ji Yeon Sung; Eun Jung Bae; Seungman Park; So Yeon Kim; Ye Jin Hyun; Sung Sup Park; Moon-Woo Seong
Journal:  Ann Lab Med       Date:  2014-08-21       Impact factor: 3.464

6.  EMQN best practice guidelines for the molecular genetic testing and reporting of chromosome 11p15 imprinting disorders: Silver-Russell and Beckwith-Wiedemann syndrome.

Authors:  Katja Eggermann; Jet Bliek; Frédéric Brioude; Elizabeth Algar; Karin Buiting; Silvia Russo; Zeynep Tümer; David Monk; Gudrun Moore; Thalia Antoniadi; Fiona Macdonald; Irène Netchine; Paolo Lombardi; Lukas Soellner; Matthias Begemann; Dirk Prawitt; Eamonn R Maher; Marcel Mannens; Andrea Riccio; Rosanna Weksberg; Pablo Lapunzina; Karen Grønskov; Deborah Jg Mackay; Thomas Eggermann
Journal:  Eur J Hum Genet       Date:  2016-05-11       Impact factor: 4.246

7.  Unbalanced segregation of a paternal t(9;11)(p24.3;p15.4) translocation causing familial Beckwith-Wiedemann syndrome: a case report.

Authors:  Caroline Lekszas; Indrajit Nanda; Barbara Vona; Julia Böck; Farah Ashrafzadeh; Nahid Donyadideh; Farnoosh Ebrahimzadeh; Najmeh Ahangari; Reza Maroofian; Ehsan Ghayoor Karimiani; Thomas Haaf
Journal:  BMC Med Genomics       Date:  2019-06-07       Impact factor: 3.063

Review 8.  Diagnosis and Management of Beckwith-Wiedemann Syndrome.

Authors:  Kathleen H Wang; Jonida Kupa; Kelly A Duffy; Jennifer M Kalish
Journal:  Front Pediatr       Date:  2020-01-21       Impact factor: 3.418

9.  A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver-Russell and Beckwith-Wiedemann syndromes.

Authors:  Silvia Russo; Luciano Calzari; Alessandro Mussa; Ester Mainini; Matteo Cassina; Stefania Di Candia; Maurizio Clementi; Sara Guzzetti; Silvia Tabano; Monica Miozzo; Silvia Sirchia; Palma Finelli; Paolo Prontera; Silvia Maitz; Giovanni Sorge; Annalisa Calcagno; Mohamad Maghnie; Maria Teresa Divizia; Daniela Melis; Emanuela Manfredini; Giovanni Battista Ferrero; Vanna Pecile; Lidia Larizza
Journal:  Clin Epigenetics       Date:  2016-03-01       Impact factor: 6.551

10.  Frequency of KCNQ1 variants causing loss of methylation of Imprinting Centre 2 in Beckwith-Wiedemann syndrome.

Authors:  Carla Eßinger; Stephanie Karch; Ute Moog; György Fekete; Anna Lengyel; Eva Pinti; Thomas Eggermann; Matthias Begemann
Journal:  Clin Epigenetics       Date:  2020-05-11       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.